Made available in DSpace on 2022-04-28T17:22:47Z (GMT). No. of bitstreams: 0 Previous issue date: 2021-12-17; Background: There is a high demand for stroke patient data in the public health systems of middle and low-income countries. Objective: To develop a stroke databank for integrating clinical or functional data and benchmarks from stroke patients. Methods: This was an observational, cross-sectional, prospe...
Made available in DSpace on 2022-04-29T08:40:46Z (GMT). No. of bitstreams: 0 Previous issue date: 2022-02-25; Objectives: Cerebral reperfusion therapy is recommended for the treatment of acute ischemic stroke. However, the outcomes of patients receiving this therapy in middle- and low-income countries should be better defined. This study aimed to evaluate the clinical and functional outcomes of cerebral reperfu...
Made available in DSpace on 2022-05-01T06:31:25Z (GMT). No. of bitstreams: 0 Previous issue date: 2021-07-06; Introduction: The main driver for increased stroke prevalence is the aging of the population; however, the best evidenced-based strategies for stroke treatment and prevention are not always followed for older patients. Therefore, the aim was studying the association of age with clinical outcomes (mortal...
Made available in DSpace on 2020-12-10T19:50:59Z (GMT). No. of bitstreams: 0 Previous issue date: 2020-02-03; Introduction. Stroke can lead to musculoskeletal and respiratory dysfunction, chronic deconditioning, and functional limitations, as well as long-term complications. Objective. The aim of this study was to evaluate the association between respiratory function and grip strength in the acute phase of stro...
Made available in DSpace on 2019-10-06T16:37:31Z (GMT). No. of bitstreams: 0 Previous issue date: 2019-05-01. Added 1 bitstream(s) on 2021-07-15T14:35:45Z : No. of bitstreams: 1 S0004-282X2019000500315.pdf: 206632 bytes, checksum: 2b9331b960a1f32682d0edfd298577f1 (MD5); Embolic stroke of undetermined source (ESUS) is an important group of cryptogenic strokes that are in evidence due recent ongoing trials. We re...